# EDGAR Filing Document

**Accession Number:** 0001850119
**File Stem:** 0001104659-26-016115
**Filing Date:** 2026-2
**Character Count:** 2432
**Document Hash:** a89419a57f803415105c62e9753585bf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-016115.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0001104659-26-016115

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260217

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Century Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001850119
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 842040295
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 25 N 38TH STREET, 11TH FLOOR
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104
- **BUSINESS PHONE:** 215-981-4000

**MAIL ADDRESS:**
- **STREET 1:** 25 N 38TH STREET, 11TH FLOOR
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104

**Century Therapeutics, Inc.**

**25 North 38<sup>th</sup> Street, 11<sup>th</sup> Floor** **<br> Philadelphia, Pennsylvania 19104**

February 17, 2026

<u>VIA EDGAR</u>

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-7553

Re: Century Therapeutics, Inc. <br> Registration Statement on Form S-3 <br> Filed February 5, 2026, 2026 (File No. 333-293228)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the "***Company***") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-293228) (the "***Registration Statement***") be accelerated so that the Company's Registration Statement will become effective at 4:05 P.M., Eastern Time, on January 17, 2026, or as soon thereafter as is practicable.

Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.

[*Remainder of the page intentionally left blank*]

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| **CENTURY THERAPEUTICS, INC.** | **CENTURY THERAPEUTICS, INC.** | **CENTURY THERAPEUTICS, INC.** |
| By: | /s/ Brent Pfeiffenberger, Pharm.D. | /s/ Brent Pfeiffenberger, Pharm.D. |
|  | Name: | Brent Pfeiffenberger, Pharm.D. |
|  | Title: | President and Chief Executive Officer |

---